PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Clinical trials for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY DISEASE, CHRONIC OBSTRUCTIVE trials appear
Sign up with your email to follow new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can pharmacists help manage COPD as well as specialists? large VA study aims to find out.
Disease control Recruiting nowThis study tests whether clinical pharmacists can provide COPD care that is as good as care from lung specialists. About 4,000 veterans with COPD will receive treatment recommendations from either a pharmacist or a specialist, sent to their primary care doctor. The goal is to see…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Phase: NA • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New drug aims to cut COPD Flare-Ups in patients with specific inflammation
Disease control Recruiting nowThis study tests a new medicine called depemokimab for people with moderate to severe COPD who have a type of inflammation called type 2. The goal is to see if adding this drug to standard treatment can reduce the number of serious flare-ups and improve breathing. About 1,200 par…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New drug aims to cut dangerous COPD attacks in patients with specific inflammation
Disease control Recruiting nowThis study tests a new medicine called depemokimab for adults aged 40 to 80 with moderate to severe COPD and type 2 inflammation. The goal is to see if adding this drug to standard treatment can reduce the number of moderate or severe flare-ups that require steroids, antibiotics,…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug aims to cut dangerous lung attacks in COPD patients
Disease control Recruiting nowThis study tests an experimental drug called depemokimab in adults aged 40-80 with moderate to severe COPD and type 2 inflammation. The goal is to see if adding this medicine to standard care can reduce the number of moderate or severe flare-ups (exacerbations) that require stero…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Real-World check: does this triple inhaler help COPD patients breathe easier?
Symptom relief Recruiting nowThis study pools data from multiple countries to see how a triple-combination inhaler (BGF) affects COPD symptoms and quality of life in routine care. About 2,000 adults with moderate-to-severe COPD who are starting BGF will be followed for up to a year. The main goal is to measu…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 26, 2026 08:29 UTC
-
Stem cells show promise for COPD lung repair
Knowledge-focused Recruiting nowThis study tests whether a patient's own stem cells (iPS cells) can repair damaged lung tissue in a lab dish. Researchers will take small lung samples from 50 people—COPD patients, smokers without COPD, and non-smokers—and grow them in the lab. They will then add stem cells to se…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated May 26, 2026 08:44 UTC
-
Breath test may replace needles for COPD patients in ER
Knowledge-focused Recruiting nowThis study looks at whether measuring carbon dioxide in a person's breath (EtCO2) can help doctors quickly tell how serious a COPD flare-up is. Researchers will watch 240 adults who come to the emergency room with breathing trouble. If EtCO2 works well, it could reduce the need f…
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 26, 2026 08:28 UTC
-
Can aspirin ease COPD? new study seeks the right dose
Knowledge-focused Recruiting nowThis study looks at whether aspirin can help people with COPD by reducing inflammation caused by overactive blood cells called platelets. Researchers will test two different aspirin doses in 48 former smokers with COPD to see which one works better. The goal is to find the right …
Matched conditions: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC